Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice.

Kenny S, Gamble J, Lyons S, Vlatkovic N, Dimaline R, Varro A, Dockray GJ.

Endocrinology. 2013 Feb;154(2):718-26. doi: 10.1210/en.2012-1913. Epub 2012 Dec 18.

2.

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice.

Gamble J, Kenny S, Dockray GJ.

Regul Pept. 2013 Aug 10;185:9-13. doi: 10.1016/j.regpep.2013.06.005. Epub 2013 Jun 28.

3.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
4.

The role of plasminogen activator inhibitor-1 in gastric mucosal protection.

Kenny S, Steele I, Lyons S, Moore AR, Murugesan SV, Tiszlavicz L, Dimaline R, Pritchard DM, Varro A, Dockray GJ.

Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G814-22. doi: 10.1152/ajpgi.00017.2013. Epub 2013 Mar 14.

5.

Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.

Nørsett KG, Steele I, Duval C, Sammut SJ, Murugesan SV, Kenny S, Rainbow L, Dimaline R, Dockray GJ, Pritchard DM, Varro A.

Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G446-53. doi: 10.1152/ajpgi.00527.2010. Epub 2010 Dec 30.

6.

Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats.

de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE.

PLoS One. 2012;7(3):e32967. doi: 10.1371/journal.pone.0032967. Epub 2012 Mar 7.

7.

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.

Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS.

J Korean Med Sci. 1996 Feb;11(1):33-7.

8.

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.

J Hepatol. 1999 Oct;31(4):703-11.

PMID:
10551395
9.

Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.

Kawasaki K, Hayashi Y, Wang Y, Suzuki S, Morita Y, Nakamura T, Narita K, Doe W, Itoh H, Kuroda Y.

J Gastroenterol Hepatol. 1998 Sep;13(9):936-44.

PMID:
9794194
10.

Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.

Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.

J Lab Clin Med. 2004 Aug;144(2):69-77.

PMID:
15322501
12.
13.

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.

Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.

J Cancer Res Clin Oncol. 2000 Nov;126(11):641-6.

PMID:
11079728
15.
16.

Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.

Plebani M, Herszènyi L, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F.

Clin Exp Metastasis. 1997 Jul;15(4):418-25.

PMID:
9219730
17.

Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.

Gourcerol G, Wang L, Wang YH, Million M, Taché Y.

Endocrinology. 2007 Dec;148(12):6115-23. Epub 2007 Oct 11.

PMID:
17932219
18.

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.

Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Nöel A, Foidart JM.

FASEB J. 2002 Feb;16(2):147-54.

PMID:
11818362
19.

Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937.

Peiretti F, Fossat C, Anfosso F, Alessi MC, Henry M, Juhan-Vague I, Nalbone G.

Blood. 1996 Jan 1;87(1):162-73.

20.

Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity.

Iwasaki Y, Maejima Y, Suyama S, Yoshida M, Arai T, Katsurada K, Kumari P, Nakabayashi H, Kakei M, Yada T.

Am J Physiol Regul Integr Comp Physiol. 2015 Mar 1;308(5):R360-9. doi: 10.1152/ajpregu.00344.2014. Epub 2014 Dec 24.

Supplemental Content

Support Center